FindTrial
Sign In

Study for the efficacy and influencing factors of different protocols in the treatment of Helicobacter pylori eradication

Study for the efficacy and influencing factors of different protocols in the treatment of Helicobacter pylori eradication

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021421
Enrollment
Unknown
Registered
2019-02-20
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the disease associated with Helicobacter pylori

Interventions

LCA:standard triple therapy
LBCA:quadruple therapy
LBiCA:standard triple therapy plus probiotics

Sponsors

the First Affiliated Hospital of Guangxi University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Outpatients with current H.pylori-infected chronic gastritis and peptic ulcer were chosen to our research.

Exclusion criteria

Exclusion criteria: 1. Gastrectomy history; 2. Gastric cancer; 3. Had received any antibiotic, bismuth compounds, PPI within 1 year before the study,and recieved H.pylori eradication before; 4. Aged 18 to 70 years; 5. Had chronic renal failure, hepatic disease, congestive heart failure or HIV infection; 6. Pregnancy or breast-feeding period; 7. Inability to follow up.

Design outcomes

Primary

MeasureTime frame
Carbon breath test;—

Countries

China

Contacts

Public ContactTang Yanbo

the First Affiliated Hospital of Guangxi University of Science and Technology

doctyb@126.com+86 13677727629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026